Lantus Buyers Demand Info On More Sanofi Injector Patents
By Matthew Perlman ( August 26, 2020, 10:38 PM EDT) -- Buyers of Sanofi's Lantus insulin treatments told a Massachusetts federal court Wednesday the company has wrongly refused to hand over documents about a number of patents for an injector device after the First Circuit revived their antitrust case based on arguments surrounding a single patent....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.